MedPath

Eye & ENT Hospital of Fudan University

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

103

Active:3
Completed:19

Trial Phases

6 Phases

Early Phase 1:6
Phase 1:2
Phase 2:8
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (84 trials with phase data)• Click on a phase to view related trials

Not Applicable
58 (69.0%)
Phase 2
8 (9.5%)
Early Phase 1
6 (7.1%)
Phase 4
6 (7.1%)
Phase 3
4 (4.8%)
Phase 1
2 (2.4%)

Anti-IL-5 Therapy With Simple Polypectomy Versus Extended Endoscopic Sinus Surgery for CRSwNP

Not Applicable
Not yet recruiting
Conditions
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Interventions
Procedure: Simple Polypectomy
Procedure: Extended Endoscopic Sinus Surgery
First Posted Date
2025-10-01
Last Posted Date
2025-10-01
Lead Sponsor
Eye & ENT Hospital of Fudan University
Target Recruit Count
360
Registration Number
NCT07200336
Locations
🇨🇳

The First Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing Municipality, China

🇨🇳

The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China

🇨🇳

The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China

and more 14 locations

Application of an Ashridge Training Model-Based Ethics and Moral Course in Newly Graduated Nurses

Not Applicable
Completed
Conditions
Professional Sense of Mission
Professional Benefit Perception
Humanistic Care Ability
Theoretical Knowledge and Practical Skills Performance
New Graduated Nurses
The Ethics and Moral Course
First Posted Date
2025-09-25
Last Posted Date
2025-09-25
Lead Sponsor
Eye & ENT Hospital of Fudan University
Target Recruit Count
120
Registration Number
NCT07193238
Locations
🇨🇳

EYE & ENT Hospital, Fudan University, Shanghai, China

Intracochlear Injection of Glucocorticoid

Not Applicable
Not yet recruiting
Conditions
Sudden Sensorineural Hearing Loss (SSNHL)
Interventions
Drug: intracochlear triamcinolone acetonide injection
Drug: intracochlear injection of dexamethasone through the round window membrane
Drug: intracochlear dexamethasone injection and intratympanic dexamethasone injection
Drug: intratympanic dexamethasone injection
First Posted Date
2025-08-21
Last Posted Date
2025-08-21
Lead Sponsor
Eye & ENT Hospital of Fudan University
Target Recruit Count
150
Registration Number
NCT07134075
Locations
🇨🇳

Fenyang Road 83, Shanghai, Shanghai, China

Efficacy and Safety of LLM-Based CBT for Tinnitus

Not Applicable
Recruiting
Conditions
Tinnitus
First Posted Date
2025-08-01
Last Posted Date
2025-09-08
Lead Sponsor
Eye & ENT Hospital of Fudan University
Target Recruit Count
78
Registration Number
NCT07097909
Locations
🇨🇳

Fudan University Eye Ear Nose and Throat Hospital, Otorhinolaryngology Department, Shanghai, Shanghai Municipality, China

Toric Intraocular Lens Implantation for Pediatric Aphakia

Not Applicable
Completed
Conditions
Pediatric Cataract
Congenital Cataract
First Posted Date
2025-07-28
Last Posted Date
2025-09-08
Lead Sponsor
Eye & ENT Hospital of Fudan University
Target Recruit Count
236
Registration Number
NCT07088796
Locations
🇨🇳

Eye and ENT hospital Fudan University, Shanghai, Shanghai Municipality, China

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 21
  • Next

News

GenEditBio Doses First Patient in World's First In Vivo CRISPR Trial for TGFBI Corneal Dystrophy

GenEditBio has dosed the first patient in a groundbreaking investigator-initiated trial of GEB-101, marking the world's first clinical study of an in vivo CRISPR-Cas ribonucleoprotein-based genome editing therapy for TGFBI corneal dystrophy.

Bilateral Gene Therapy Restores Hearing in Both Ears for Children with Inherited Deafness

Five children with DFNB9 inherited deafness gained hearing in both ears after receiving bilateral gene therapy targeting OTOF gene mutations in a world-first clinical trial.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.